Literature DB >> 12172224

Diagnosis and treatment of voiding dysfunction caused by urethral obstruction after anti-incontinence surgery.

John K Nguyen1.   

Abstract

Voiding dysfunction after surgical treatment of stress incontinence may occur as a result of urethral obstruction secondary to hyperelevation of the bladder neck. The diagnosis of urethral obstruction after anti-incontinence surgery is often based upon patient symptomatology and physical examination without confirmation by urodynamic, endoscopic or other diagnostic studies. Urethrolysis seems effective in treating urethral obstruction and voiding dysfunction after surgical treatment of stress urinary incontinence. The reported high success rates of less-invasive procedures have not been confirmed by larger studies. Randomized prospective clinical trials are required to determine the optimal surgical treatment for prolonged voiding dysfunction after anti-incontinence procedures.

Entities:  

Mesh:

Year:  2002        PMID: 12172224     DOI: 10.1097/00006254-200207000-00024

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  4 in total

Review 1.  Evaluation and management of urinary retention after a suburethral sling procedure in women.

Authors:  Lysanne Campeau; Tala Al-Afraa; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

2.  Risk factors associated with voiding dysfunction after anti-incontinence surgery.

Authors:  Sue-Min Chung; Yeo-Jung Moon; Myung-Jae Jeon; Sei-Kwang Kim; Sang-Wook Bai
Journal:  Int Urogynecol J       Date:  2010-08-04       Impact factor: 2.894

3.  The evolution of surgical treatment for female stress urinary incontinence: era of mid-urethral slings.

Authors:  Young-Suk Lee; Ha Na Lee; Kyu-Sung Lee
Journal:  Korean J Urol       Date:  2010-04-20

Review 4.  Treatment of postoperative voiding dysfunction following incontinence surgery.

Authors:  Danielle D Sweeney; Wendy W Leng
Journal:  Curr Urol Rep       Date:  2005-09       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.